Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYTOCOR: Reduced Duration CMV Prophylaxis in Lung Transplant
NCT03699254Phase 3Completed
- Sponsor
- Maimónides Institute of Biomedical Research of Córdoba
- Start
- Apr 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valganciclovir in cytomegalovirus infection (CMV), sponsored by Maimónides Institute of Biomedical Research of Córdoba. Started Apr 2019; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT03699254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03699254.